Emicizumab-kxwh Subcutaneous and Vantrela ER
Determining the interaction of Emicizumab-kxwh Subcutaneous and Vantrela ER and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: hydrocodone
Brand name: Hysingla ER, Vantrela ER, Zohydro ER
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Vaprisol
- Emicizumab-kxwh Subcutaneous-Vaqta
- Emicizumab-kxwh Subcutaneous-Vaqta Pediatric
- Emicizumab-kxwh Subcutaneous-Vardenafil
- Emicizumab-kxwh Subcutaneous-Vardenafil Hydrochloride
- Emicizumab-kxwh Subcutaneous-Vardenafil ODT
- Vantrela ER-Emla
- Vantrela ER-Emla Topical
- Vantrela ER-Emo-Cort Scalp Solution Topical application
- Vantrela ER-Emo-Cort Topical application
- Vantrela ER-Emoquette
- Vantrela ER-Empagliflozin